ASCO 2013 Annual Meeting Public Saturday - ASCO


Powered by SmugMug Log In
Chicago, IL - ASCO 2013 Annual Meeting: - Dieter Koeberle, MD, during "#3503 Dieter Koeberle, MD Bevacizumab continuation versus no continuation after first-line chemo-bevacizumab therapy in patients with metastatic colorectal cancer: A randomized phase _ noninferiority trial(SAKK41/06)." at the American Society for Clinical Oncology (ASCO) Annual Meeting here today, Saturday June 1, 2013.  Over 30,000 physicians, researchers and healthcare professionals from over 100 countries are attending the meeting which is being held at the McCormick Convention center and features the latest cancer research in the areas of basic and clinical science. Photo by © ASCO/Brian Powers 2013 Technical Questions: todd@toddbuchanan.com; ASCO Contact: photos@asco.org

Chicago, IL - ASCO 2013 Annual Meeting: - Dieter Koeberle, MD, during "#3503 Dieter Koeberle, MD Bevacizumab continuation versus no continuation after first-line chemo-bevacizumab therapy in patients with metastatic colorectal cancer: A randomized phase _ noninferiority trial(SAKK41/06)." at the American Society for Clinical Oncology (ASCO) Annual Meeting here today, Saturday June 1, 2013. Over 30,000 physicians, researchers and healthcare professionals from over 100 countries are attending the meeting which is being held at the McCormick Convention center and features the latest cancer research in the areas of basic and clinical science. Photo by © ASCO/Brian Powers 2013 Technical Questions: todd@toddbuchanan.com; ASCO Contact: photos@asco.org